Key result
Antiplatelet therapy, including aspirin, remains a mainstay of treatment for cardiovascular diseases by targeting platelet activation and arterial thrombus formation.
Design
Review
Authors
Loading...
Upholds antiplatelet therapy in CVD care; leaves open refinements with emerging agents.
This review discusses the role of platelets in cardiovascular disease and the mechanisms of antiplatelet therapies, including aspirin and newer agents.
Reiter et al. (2005) conducted a review in Cardiovascular diseases. Antiplatelet drugs was evaluated. Antiplatelet therapy, including aspirin, remains a mainstay of treatment for cardiovascular diseases by targeting platelet activation and arterial thrombus formation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: